PURPOSE: Metabolic syndrome (MS) plays a potential role in the etiology of benign prostatic hyperplasia (BPH).
Recent studies have reported on an association between MS and BPH. However, there has been no consensus on recent results. This study was conducted to evaluate the associations among prostate-specific antigen (PSA), prostate volume (PV), and metabolic components in men who visited our health promotion center.
MATERIALS AND METHODS: During the period from January 2005 to December 2010, 521 consecutive men (age range, 40 to 70 years) who underwent transrectal ultrasonography were enrolled in this retrospective study. The health screening program includes blood pressure, body measurements (height, weight, waist circumference, body mass index), biochemical analysis (serum glucose, total cholesterol, triglycerides, high-density and low-density lipoprotein cholesterol, fasting plasma glucose, tumor markers), stool and urine analysis, and a detailed clinical examination.
RESULTS: The serum PSA level and PV were significantly higher in patients with MS than in patients without MS, retrospectively (p< 0.001, p< 0.001). Patients with more than one metabolic component were significantly more likely to have a larger PV and higher serum PSA level. The serum PSA level and PV were increased in a similar manner with the increasing sum of MS components (p< 0.0001, p< 0.0001).
CONCLUSIONS: The MS components were associated with larger PV and higher serum PSA level. Therefore, each MS component could be an important factor in BPH development and management.
Written by:
Byun HK, Sung YH, Kim W, Jung JH, Song JM, Chung HC. Are you the author?
Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea.
Reference: Korean J Urol. 2012 Nov;53(11):774-8.
doi: 10.4111/kju.2012.53.11.774
PubMed Abstract
PMID: 23185669
